BNP PARIBAS FINANCIAL MARKETS - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 123 filers reported holding ARRAY BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 3.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$3,035,078,000
+153.8%
65,510
+33.6%
0.01%
+100.0%
Q1 2019$1,195,888,000
+395.6%
49,052
+189.6%
0.00%
+200.0%
Q4 2018$241,324,000
-31.3%
16,935
-26.7%
0.00%0.0%
Q3 2018$351,257,000
+0.8%
23,109
+11.3%
0.00%0.0%
Q2 2018$348,302,000
-88.6%
20,757
-88.9%
0.00%
-83.3%
Q1 2018$3,049,017,000
+483.1%
186,827
+357.3%
0.01%
+500.0%
Q4 2017$522,893,000
+126.0%
40,851
+117.1%
0.00%0.0%
Q3 2017$231,400,000
+39.4%
18,813
-5.1%
0.00%0.0%
Q2 2017$165,944,000
+739.2%
19,826
+796.3%
0.00%
Q1 2017$19,775,000
-25.2%
2,212
-26.5%
0.00%
Q4 2016$26,449,000
-61.2%
3,009
-70.2%
0.00%
Q3 2016$68,094,000
+240.2%
10,088
+79.4%
0.00%
Q2 2016$20,014,000
-85.4%
5,622
-82.7%
0.00%
Q4 2015$136,864,000
+2.9%
32,432
+11.2%
0.00%
Q3 2015$132,992,000
+57.2%
29,165
+148.5%
0.00%
Q2 2015$84,609,000
+246.6%
11,735
+254.3%
0.00%
Q1 2015$24,409,000
-8.4%
3,312
-55.6%
0.00%
Q3 2014$26,639,000
+251.0%
7,462
+392.5%
0.00%
Q4 2013$7,590,000
-96.2%
1,515
-95.2%
0.00%
Q3 2013$197,939,000
+4.2%
31,823
-24.0%
0.00%
Q2 2013$190,017,00041,8540.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2014
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders